MBiotech Program News

05/10/2012 - 15:00 - Biological markers increase clinical trial success rate of new breast cancer drugs

Lanna Crucefix news.utm@utoronto.ca Using biological markers—genetic characteristics that are associated with some patients with breast cancer—can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga. “It...

18/09/2012 - 12:00 - MBiotech alumnus publishes in The Journal of Rheumatology

MBiotech alumnus, Kavisha Jayasundara, co-publishes paper in The Journal of Rheumatology based on research conducted while an MBiotech student, under the  supervision of Dr. Jayson Parker and in collaboration with Dr. Edward Keystone, Mount Sinai hospital. The paper provides, for the first time, a quantitative estimate for the risk of...

30/07/2012 - 11:30 - Dr. Revers is taking a sabbatical

The Associate Director of the MBiotech Program, Leigh Revers, is currently on sabbatical. Read about his exploits in London on his My First Sabbatical daily blog.

04/07/2012 - 14:00 - MBiotech Celebrates 10 Years of Success

On Thursday, June 7, 2012, the Master of Biotechnology Program at the University of Toronto Mississauga celebrated 10 years of successful graduates at a gala event on campus. This event brought together over 150 alumni from 2003-2011, along with dozens of current students, faculty, staff and industry partners. Industry partnership awards were...

10/04/2012 - 14:00 - Congratulations to Ilia Tikhomirov, Class of 2007

Ilia Tikhomirov, President and CEO of AvidBiologics Inc., (MBiotech Class of 2007) announced on April 5 that AvidBiologics Inc. has raised Series A capital from private investors and expanded its board of directors. The funds will be used to advance the company's antibody-drug conjugate (ADC) programs into Investigational New Drug (IND)...

Pages